BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ahmed M, Wuethrich A, Constantin N, et al. (2023) Liquid Biopsy Snapshots of Key Phosphoproteomic Pathways in Lung Cancer Patients for Diagnosis and Therapy Monitoring. Analytical Chemistry |
| Paz-Ares LG, Ciuleanu T, Pluzanski A, et al. (2022) Safety of First-line Nivolumab Plus Ipilimumab in Patients With Metastatic Non-Small Cell Lung Cancer: A Pooled Analysis of CheckMate 227, CheckMate 568, and CheckMate 817. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer |
| Sadeghi Rad H, Bahrami T, Layeghi SM, et al. (2022) Immunotherapeutic targets in non-small cell lung cancer. Immunology |
| Shiravand Y, Khodadadi F, Kashani SMA, et al. (2022) Immune Checkpoint Inhibitors in Cancer Therapy. Current Oncology (Toronto, Ont.). 29: 3044-3060 |
| Brims FJ, McWilliams A, Harden SV, et al. (2022) Lung cancer: progress with prognosis and the changing state of play. The Medical Journal of Australia. 216: 334-336 |
| Herath S, Sadeghi Rad H, Radfar P, et al. (2022) The Role of Circulating Biomarkers in Lung Cancer. Frontiers in Oncology. 11: 801269 |
| Malapelle U, Pisapia P, Addeo A, et al. (2021) Liquid biopsy from research to clinical practice: focus on non-small cell lung cancer. Expert Review of Molecular Diagnostics. 1-14 |
| Kulasinghe A, O'Leary C, Monkman J, et al. (2021) The identification of circulating tumour DNA using MassARRAY technology in non-small-cell lung cancer (NSCLC). Lung Cancer (Amsterdam, Netherlands). 160: 73-77 |
| Rad HS, Rad HS, Shiravand Y, et al. (2021) The Pandora's box of novel technologies that may revolutionize lung cancer. Lung Cancer (Amsterdam, Netherlands). 159: 34-41 |
| Ahern E, Solomon BJ, Hui R, et al. (2021) Neoadjuvant immunotherapy for non-small cell lung cancer: right drugs, right patient, right time? Journal For Immunotherapy of Cancer. 9 |